West Michigan Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.04M Hold
66,662
0.89% 25
2026
Q1
$4.04M Buy
+66,662
New +$3.89M 0.89% 25
2025
Q3
Sell
-8,002
Closed -$370K 265
2025
Q2
$370K Buy
+8,002
New +$393K 0.1% 142
2023
Q2
Sell
-3,007
Closed -$208K 247
2023
Q1
$208K Buy
3,007
+172
+6% +$12.1K 0.12% 140
2022
Q4
$204K Buy
+2,835
New +$214K 0.15% 111
2022
Q3
Sell
-5,088
Closed -$392K 114
2022
Q2
$392K Sell
5,088
-739
-13% -$56.3K 0.34% 65
2022
Q1
$426K Sell
5,827
-4,998
-46% -$336K 0.29% 65
2021
Q4
$675K Buy
+10,825
New +$635K 0.5% 46

Other funds holding BMY

West Michigan Advisors's BMY Position: Q2 2026 in Review

West Michigan Advisors held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 66,662 shares worth $4.04M. The position accounts for 0.89% of the portfolio, ranked #25.

West Michigan Advisors first reported a position in BMY in Q4 2021 and has held it in 8 quarters since. 830 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • West Michigan Advisors held 66,662 shares of Bristol-Myers Squibb worth $4.04M as of Q2 2026.
  • West Michigan Advisors left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.89% of West Michigan Advisors's portfolio in Q2 2026, its #25 holding.
  • West Michigan Advisors first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 8 quarters since.
  • 830 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on West Michigan Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.